- Antidepressant Medication Use In Pregnancy
Antidepressant Medication Use In Pregnancy
A study published by JAMA Psychiatry reports no evidence of an association between intellectual disability in children and mothers who took antidepressant medication during pregnancy when other mitigating factors, such as parental age and underlying psychiatric disorder, were considered.
Intellectual disability is defined by an IQ below 70 with deficits that impair everyday functioning.
Sven Sandin, Ph.D., of the Ichan School of Medicine at Mount Sinai in New York, and coauthors, including Abraham Reichenberg, Ph.D., also of the Icahn School of Medicine, used Swedish national registers to conduct a population-based study of 179,007 children born from 2006 through 2007 and followed-up from birth until a diagnosis of intellectual disability, death or the end of the follow-up in 2014.
The authors estimated the relative risk, or probability, of intellectual disability in children exposed during pregnancy to antidepressants or not and the analyses were adjusted for other potential mitigating factors.
Of the 179,007 children included in the study, intellectual disability was diagnosed in 37 (0.9 percent) exposed to antidepressants and in 819 children (0.5 percent) who were unexposed to antidepressants, according to the results.
A higher estimate of relative risk that was observed by the researchers before accounting for parental factors was reduced to a statistically insignificant estimated relative risk when those factors were considered, the results show.
The study notes limitations and acknowledges the outcome was rare. The number of children diagnosed with intellectual disability during the follow-up period of the first 7 to 8 years after birth was 873 (0.5 percent), which is comparable to some other prevalence estimates, according to the article.
“After adjustment for confounding factors, however, the current study did not find evidence of an association between ID [intellectual disability] and maternal antidepressant medication use during pregnancy. Instead, the association may be attributable to mechanisms integral to other factors, such as parental age and underlying psychiatric disorder,” the study concludes.
DISCLAIMER: Bankix Systems Ltd is the registered name of a Canadian firm since 2003, and bankixsystems.com is its OFFICIAL website. Besides these entities, we have no relationship with anyone, business, website, or any other entity anywhere in the world, claiming to be Bankix Systems, or using a similar name, and creating the impression that it has some connection with our company. We do not endorse and are therefore, not responsible for any act or lack thereof by any such entity. Bankix Systems Ltd is also not responsible for the content of the description of products and services linked to our site nor does it necessarily endorse them. The information here provided is not for diagnosing/treating your health concerns. Kindly contact your doctor or health care professional for all your healthcare requirements.
Contents © 2003-2019, BankixSystems.com. All rights reserved. Unauthorized reproduction strictly prohibited. Information based on best available resources. Opinions are current and subject to change.